Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them. Read Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2021/03/TS.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-02-10 13:00:472021-03-01 13:02:11Vaccines Versus the Mutants